Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NUPUR GUPTA

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1588945380
CMS profile
920775
Location
INDIANAPOLIS, IN

General Payments · PY2018–2024

$19,067.04

  • Reported across 37 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$8,245.22

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Fresenius USA Marketing, Inc. $5,276.77 9
AKEBIA THERAPEUTICS INC $2,906.47 5
Amgen Inc. $61.98 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $27.84 2
PY2019 $40.16 2
PY2020 $882.06 2
PY2021 $5,790.45 6
PY2022 $4,018.25 7
PY2023 $63.06 3
PY2024 $8,245.22 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AKEBIA THERAPEUTICS INC $8.71 04/25/2024 Food and Beverage Undisputed 01/23/2026 1145824871 CMS
AKEBIA THERAPEUTICS INC $2,655.00 07/26/2024 Consulting Fee Undisputed 01/23/2026 1145832037 CMS
AKEBIA THERAPEUTICS INC $94.87 08/14/2024 Food and Beverage Undisputed 01/23/2026 1145824873 CMS
AKEBIA THERAPEUTICS INC $9.46 10/25/2024 Food and Beverage Undisputed 01/23/2026 1145829666 CMS
AKEBIA THERAPEUTICS INC $138.43 12/17/2024 Food and Beverage Undisputed 01/23/2026 1145831771 CMS
Amgen Inc. $61.98 10/26/2024 Food and Beverage Undisputed 01/23/2026 1117569503 CMS
Fresenius USA Marketing, Inc. $199.94 03/19/2024 Travel and Lodging Undisputed 01/23/2026 1154195620 CMS
Fresenius USA Marketing, Inc. $68.02 03/20/2024 Travel and Lodging Undisputed 01/23/2026 1154195616 CMS
Fresenius USA Marketing, Inc. $185.01 03/20/2024 Food and Beverage Undisputed 01/23/2026 1154195618 CMS
Fresenius USA Marketing, Inc. $286.60 03/20/2024 Travel and Lodging Undisputed 01/23/2026 1154195624 CMS
Fresenius USA Marketing, Inc. $558.20 03/20/2024 Travel and Lodging Undisputed 01/23/2026 1154195628 CMS
Fresenius USA Marketing, Inc. $2,400.00 03/20/2024 Consulting Fee Undisputed 01/23/2026 1154200420 CMS
Fresenius USA Marketing, Inc. $450.00 07/16/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 1154195626 CMS
Fresenius USA Marketing, Inc. $229.00 10/23/2024 Food and Beverage Undisputed 01/23/2026 1154195622 CMS
Fresenius USA Marketing, Inc. $900.00 10/23/2024 Consulting Fee Undisputed 01/23/2026 1154200418 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.